Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma

Background: Esophageal adenocarcinoma (EAC) remains a leading cause of cancer-related deaths worldwide and demonstrates a predominant rising incidence in Western countries. Recently, immunotherapy has dramatically changed the landscape of treatment for many advanced cancers, with the benefit in EAC...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Genet
Main Authors: Liu, Zaoqu, Liu, Long, Jiao, Dechao, Guo, Chunguang, Wang, Libo, Li, Zhaonan, Sun, Zhenqiang, Zhao, Yanan, Han, Xinwei
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Genetics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8166246/
https://ncbi.nlm.nih.gov/pubmed/34079583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.669694
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki